HUP9800272A2 - Penciclovir alkalmazása emberi herpeszvírus-8 kezelésére - Google Patents

Penciclovir alkalmazása emberi herpeszvírus-8 kezelésére

Info

Publication number
HUP9800272A2
HUP9800272A2 HU9800272A HUP9800272A HUP9800272A2 HU P9800272 A2 HUP9800272 A2 HU P9800272A2 HU 9800272 A HU9800272 A HU 9800272A HU P9800272 A HUP9800272 A HU P9800272A HU P9800272 A2 HUP9800272 A2 HU P9800272A2
Authority
HU
Hungary
Prior art keywords
treatment
virus
penciclovir
human herpes
medically
Prior art date
Application number
HU9800272A
Other languages
English (en)
Inventor
Klaus Max Esser
Richard Anthony Vere Hodge
Original Assignee
Smithkline Beecham Corporation
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation, Smithkline Beecham P.L.C. filed Critical Smithkline Beecham Corporation
Publication of HUP9800272A2 publication Critical patent/HUP9800272A2/hu
Publication of HUP9800272A3 publication Critical patent/HUP9800272A3/hu
Publication of HU226005B1 publication Critical patent/HU226005B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány hűmán herpeszvírűs-8 (HHV-8) fertőzés kezelésében ésprőfilaxisában történő felhasználásra szőlgáló gyógyszerkészítményrevőnatkőzik, amely egy gyógyászatilag elfőgadható hőrdőzó melletthatásős mennyiségben egy (A) képletű vegyületet, vagy ennek egybiőprekűrzőrát, vagy egy gyógyászatilag elfőgadható sóját, illetve azelőbbiek bármelyikének egy főszfátészter- és/vagy acilszármazékáttartalmazza. (A) ŕ
HU9800272A 1995-03-07 1996-03-05 Use of penciclovir for the treatment of human herpes-virus-8 HU226005B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9504497.0A GB9504497D0 (en) 1995-03-07 1995-03-07 Pharmaceuticals
PCT/EP1996/000933 WO1996027378A2 (en) 1995-03-07 1996-03-05 Use of penciclovir for the treatment of human herpes-virus-8

Publications (3)

Publication Number Publication Date
HUP9800272A2 true HUP9800272A2 (hu) 2000-05-28
HUP9800272A3 HUP9800272A3 (en) 2000-12-28
HU226005B1 HU226005B1 (en) 2008-02-28

Family

ID=10770731

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800272A HU226005B1 (en) 1995-03-07 1996-03-05 Use of penciclovir for the treatment of human herpes-virus-8

Country Status (23)

Country Link
US (1) US6489330B1 (hu)
EP (1) EP0814813B1 (hu)
JP (2) JPH11501625A (hu)
KR (1) KR19980702833A (hu)
CN (1) CN1138545C (hu)
AT (1) ATE254919T1 (hu)
AU (1) AU701739B2 (hu)
BR (1) BR9607663A (hu)
CA (1) CA2214406C (hu)
CY (1) CY2525B1 (hu)
CZ (1) CZ293470B6 (hu)
DE (1) DE69630876T2 (hu)
DK (1) DK0814813T3 (hu)
ES (1) ES2211949T3 (hu)
GB (1) GB9504497D0 (hu)
HK (1) HK1004373A1 (hu)
HU (1) HU226005B1 (hu)
NO (1) NO317733B1 (hu)
NZ (1) NZ303951A (hu)
PT (1) PT814813E (hu)
TR (1) TR199700921T1 (hu)
WO (1) WO1996027378A2 (hu)
ZA (1) ZA961795B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
EP2274042A4 (en) * 2008-04-11 2012-03-14 Epiphany Biosciences Inc TREATMENT AND / OR PREVENTION OF MULTIPLE SCLEROSIS
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
EP0182024B1 (en) * 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use
DE3671227D1 (de) * 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
CA2042931A1 (en) 1990-05-24 1991-11-25 Robert Zahler Fluorinated bis (hydroxymethyl) cyclobutyl purines and pyrimidines
GB9015051D0 (en) 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment

Also Published As

Publication number Publication date
CA2214406A1 (en) 1996-09-12
PT814813E (pt) 2004-04-30
AU5102296A (en) 1996-09-23
HU226005B1 (en) 2008-02-28
CA2214406C (en) 2010-12-21
ZA961795B (en) 1996-11-25
ES2211949T3 (es) 2004-07-16
MX9706759A (es) 1997-11-29
HUP9800272A3 (en) 2000-12-28
WO1996027378A3 (en) 1997-01-16
NO974101L (no) 1997-09-05
EP0814813B1 (en) 2003-11-26
DE69630876T2 (de) 2004-09-02
TR199700921T1 (xx) 1998-02-21
CN1138545C (zh) 2004-02-18
DE69630876D1 (de) 2004-01-08
NO317733B1 (no) 2004-12-13
US6489330B1 (en) 2002-12-03
AU701739B2 (en) 1999-02-04
CN1183722A (zh) 1998-06-03
JPH11501625A (ja) 1999-02-09
NZ303951A (en) 1999-07-29
NO974101D0 (no) 1997-09-05
HK1004373A1 (en) 1998-11-27
WO1996027378A2 (en) 1996-09-12
CY2525B1 (en) 2006-02-08
DK0814813T3 (da) 2004-03-22
GB9504497D0 (en) 1995-04-26
JP2007297412A (ja) 2007-11-15
BR9607663A (pt) 1998-06-16
KR19980702833A (ko) 1998-08-05
CZ293470B6 (cs) 2004-05-12
EP0814813A2 (en) 1998-01-07
CZ283197A3 (cs) 1998-02-18
ATE254919T1 (de) 2003-12-15

Similar Documents

Publication Publication Date Title
YU13695A (sh) Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
ES2132393T3 (es) Derivados de guanidina utiles en terapeutica.
PT979244E (pt) Derivados de ciclosporina, sua preparacao e composicoes farmaceuticas que os contem
CA2299361A1 (en) Use of consensus interferon in combination with il-1 receptor antagonist for treatment of patients afflicted with multiple sclerosis
TR199701497T1 (xx) Beyin �demini �nleyen terkip.
HUP9800272A2 (hu) Penciclovir alkalmazása emberi herpeszvírus-8 kezelésére
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
HK1012234A1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
CY2338B1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections.
LV5179A3 (lv) Preparats "etoksidins" teju kunga un zarnu slimibu profilaksei un arstesanai
ITMI911930A0 (it) Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico
MX9704336A (es) Uso de agentes antivirales para el tratamiento y profilaxis de infecciones latentes de herpesvirus.

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees